Usefullness of FMISO-PET/CT in head and neck cancer

Usefullness of FMISO-PET/CT in head and neck cancer - Usefullness of FMISO-PET/CT in head and neck cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016516

Enrollment

Registered

2015-02-16

Start date

2015-06-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

clinical use of F-MISO(PET tracer)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients of head and neck cancer treated with radiotherapy.

Exclusion criteria

Exclusion criteria: (1)cominication disorder (2)bad Performance Status (3)not in concent (4)women in pregnancy

Design outcomes

Primary

Measure	Time frame
comparison of 2hr and 4hr after projection comparison of FDG and FMISO reproducibility of this test change of the hypoxic resion throughout this treatment prognosis prediction planning study(dose escalation)	—

Countries

Japan

Contacts

Public ContactMichio Yoshimura

Kyoto University Hospital Department of Radiation Oncology and Image-Applied Therapy

myossy@kuhp.kyoto-u.ac.jp075-751-3762

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026